Endoscopic assisted electrochemotherapy in addition to neoadjuvant treatment of locally advanced rectal cancer: a randomized clinical phase II trial
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S413
DOI: 10.1055/s-0044-1783733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von L. Ngo-Stuyt und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
The aim of this clinical trial is to establish electrochemotherapy with bleomycin as a safe and feasible part of the standard neoadjuvant down-staging treatment of patients with locally advanced rectal cancer (UICC stage II-III) prior to intended curative surgery. The study’s primary objective is to establish safety and efficacy of electrochemotherapy treatment in locally advanced rectal cancer, while the secondary objective is to investigate changes in tumour size (down staging) and structure (grade of regression).
Methods
This was a randomized clinical trial. Patients were eligible for inclusion if they had locally advanced rectal cancer, UICC stage II-III. Patients were recruited in Region Zealand and Capitol Region in Denmark between 2017 and 2018. Patients randomized to the intervention group, were offered the standard preoperative neoadjuvant therapy, followed by a single treatment of electrochemotherapy with bleomycin and subsequent standard surgical resection. Patients in the control group received the standard preoperative neoadjuvant treatment followed by surgical resection. Electroporation was delivered through the endoscopic device EndoVe and the Cliniporator was used for pulse generation. Bleomycin (15.000 IU/m 2 x body surface area) was administered intravenously 8 minutes prior to endoscopic electroporation to ensure even distribution of bleomycin within the tumour tissue. Patients were recruited just prior to completion of neoadjuvant treatment. PET/MRI was performed as baseline outcome for standard neoadjuvant treatment. A second PET/MRI was performed in the week leading up to surgical resection as a measure of response to preoperative electroporation. The pathology report upon surgical resection will include specific tumour details on regression grading and final staging of the tumour. Follow-up was twelve weeks. Safety parameters were reviewed continuously by reviewing adverse events as they arose.
Results
Sixteen patients were included in this randomized clinical trial. Eight patients were in the intervention group and eight patients were in the control group. In the intervention group, endoscopy procedure time was between 9 to 36 minutes. Patients were treated with a minimum of 3 pulses and maximum of 15 pulses. In 7 out of 8 patients, 100% of the tumour area was successfully treated with electroporation. The last remaining patient received successful treatment of 75% of the tumour area. No serious adverse events occurred. Rectal pain was the most frequently reported (n=4) adverse event in the intervention group. PET/MRI tumour volumetric results from this study are still pending.
Conclusions
Electrochemotherapy is a safe and feasible treatment for locally advanced rectal cancer. The pending PET/MRI tumour volumetric result from this study can provide valuable data and insight into further investigation of the role of electroporation in the treatment of locally advanced rectal cancer in the future. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Ngo-Stuyt, L., Vogelsang, R., Broholm, M., Bulut, M., Seiersen, M., Jakobsen, A. L., Johannesen, H. H., Stigaard, T., Gehl, J., & Gögenur, I. (2024). Endoscopic assisted electrochemotherapy in addition to neoadjuvant treatment of locally advanced rectal cancer: a randomized clinical phase II trial. Endoscopy, 56(S 02 S 02), S413. https://doi.org/10.1055/s-0044-1783733
Vancouver
Ngo-Stuyt L, Vogelsang R, Broholm M, Bulut M, Seiersen M, Jakobsen AL, et al. Endoscopic assisted electrochemotherapy in addition to neoadjuvant treatment of locally advanced rectal cancer: a randomized clinical phase II trial. Endoscopy. 2024;56(S 02 S 02):S413. doi:10.1055/s-0044-1783733
BibTeX
@article{NgoStuyt2024,
author = {Ngo-Stuyt, L. and Vogelsang, R. and Broholm, M. and Bulut, M. and Seiersen, M. and Jakobsen, A. L. and Johannesen, H. H. and Stigaard, T. and Gehl, J. and Gögenur, I.},
title = {Endoscopic assisted electrochemotherapy in addition to neoadjuvant treatment of locally advanced rectal cancer: a randomized clinical phase II trial},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S413},
doi = {10.1055/s-0044-1783733}
}
EUVIMED